ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Interventional Pain Medicine

Top Interventional Pain Medicine Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSEPH GLAZIER MD

Interventional Pain Medicine

8,484

$556K

410
77 are 65+

59%
patients receiving schedule two controlled substances

Avg: 40%

63%
patients receiving schedule three controlled substances

Avg: 39%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 18%

$65
Average prescription price

Avg: $80

MAHENDRA SANAPATI M.D.

Interventional Pain Medicine

7,619

$395K

629
176 are 65+

50%
patients receiving schedule two controlled substances

Avg: 40%

47%
patients receiving schedule three controlled substances

Avg: 39%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 18%

$52
Average prescription price

Avg: $80

RANDALL OLIVER M.D.

Interventional Pain Medicine

5,480

$468K

392
149 are 65+

62%
patients receiving schedule two controlled substances

Avg: 40%

20%
patients receiving schedule three controlled substances

Avg: 39%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 18%

$85
Average prescription price

Avg: $80

MICHAEL WHITWORTH MD

Interventional Pain Medicine

3,821

$380K

332
104 are 65+

72%
patients receiving schedule two controlled substances

Avg: 40%

36%
patients receiving schedule three controlled substances

Avg: 39%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 18%

$99
Average prescription price

Avg: $80

AJIT PAI MD

Interventional Pain Medicine

3,576

$196K

424
190 are 65+

48%
patients receiving schedule two controlled substances

Avg: 40%

48%
patients receiving schedule three controlled substances

Avg: 39%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

9%
prescriptions for brand name drugs

Avg: 18%

$55
Average prescription price

Avg: $80

HEATHER NATH M.D

Interventional Pain Medicine

3,327

$383K

319
212 are 65+

36%
patients receiving schedule two controlled substances

Avg: 40%

46%
patients receiving schedule three controlled substances

Avg: 39%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 18%

$115
Average prescription price

Avg: $80

MANSOOR KHAN M.D.

Interventional Pain Medicine

3,322

$140K

306
76 are 65+

52%
patients receiving schedule two controlled substances

Avg: 40%

61%
patients receiving schedule three controlled substances

Avg: 39%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

6%
prescriptions for brand name drugs

Avg: 18%

$42
Average prescription price

Avg: $80

JOSEPH FORTIN D.O.

Interventional Pain Medicine

2,379

$379K

179
58 are 65+

75%
patients receiving schedule two controlled substances

Avg: 40%

28%
patients receiving schedule three controlled substances

Avg: 39%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 18%

$159
Average prescription price

Avg: $80

JOSEPH WALING MD

Interventional Pain Medicine

2,354

$219K

279
162 are 65+

38%
patients receiving schedule two controlled substances

Avg: 40%

36%
patients receiving schedule three controlled substances

Avg: 39%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 18%

$93
Average prescription price

Avg: $80

PHILLIP KINGMA M.D.

Interventional Pain Medicine

1,371

$133K

192
102 are 65+

41%
patients receiving schedule two controlled substances

Avg: 40%

40%
patients receiving schedule three controlled substances

Avg: 39%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 18%

$97
Average prescription price

Avg: $80

DAVID RATZMAN M.D.

Interventional Pain Medicine

1,351

$272K

171
133 are 65+

20%
patients receiving schedule two controlled substances

Avg: 40%

35%
patients receiving schedule three controlled substances

Avg: 39%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 18%

$201
Average prescription price

Avg: $80

MICHAEL MCFADDEN M.D.

Interventional Pain Medicine

1,316

$80K

264
193 are 65+

25%
patients receiving schedule two controlled substances

Avg: 40%

42%
patients receiving schedule three controlled substances

Avg: 39%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 18%

$61
Average prescription price

Avg: $80

CAROL HARRIS MD

Interventional Pain Medicine

1,244

$80.5K

287
106 are 65+

42%
patients receiving schedule two controlled substances

Avg: 40%

41%
patients receiving schedule three controlled substances

Avg: 39%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 18%

$65
Average prescription price

Avg: $80

WILLIAM HALL M.D.

Interventional Pain Medicine

1,082

$94.1K

182
87 are 65+

48%
patients receiving schedule two controlled substances

Avg: 40%

42%
patients receiving schedule three controlled substances

Avg: 39%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 18%

$87
Average prescription price

Avg: $80

ANITA RAO M.D.

Interventional Pain Medicine

1,048

$83.4K

283
159 are 65+

20%
patients receiving schedule two controlled substances

Avg: 40%

23%
patients receiving schedule three controlled substances

Avg: 39%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 18%

$80
Average prescription price

Avg: $80

BRIAN MCCLENIC MD

Interventional Pain Medicine

845

$44.9K

170
120 are 65+

21%
patients receiving schedule two controlled substances

Avg: 40%

35%
patients receiving schedule three controlled substances

Avg: 39%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 18%

$53
Average prescription price

Avg: $80

SHARIQ IBRAHIM MD

Interventional Pain Medicine

780

$41.4K

204
174 are 65+

15%
patients receiving schedule two controlled substances

Avg: 40%

34%
patients receiving schedule three controlled substances

Avg: 39%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 18%

$53
Average prescription price

Avg: $80

STEVEN LEVINE M.D.

Interventional Pain Medicine

587

$88.7K

154
91 are 65+

42%
patients receiving schedule two controlled substances

Avg: 40%

42%
patients receiving schedule three controlled substances

Avg: 39%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 18%

$151
Average prescription price

Avg: $80

TIMOTHY KING MD

Interventional Pain Medicine

438

$26.3K

129
95 are 65+

19%
patients receiving schedule two controlled substances

Avg: 40%

46%
patients receiving schedule three controlled substances

Avg: 39%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 18%

$60
Average prescription price

Avg: $80

TAREK SHAHBANDAR M.D.

Interventional Pain Medicine

402

$24.7K

87
46 are 65+

29%
patients receiving schedule two controlled substances

Avg: 40%

28%
patients receiving schedule three controlled substances

Avg: 39%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 18%

$61
Average prescription price

Avg: $80

ALEXANDRU NITU MD

Interventional Pain Medicine

356

$44.3K

74
45 are 65+

23%
patients receiving schedule two controlled substances

Avg: 40%

47%
patients receiving schedule three controlled substances

Avg: 39%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 18%

$124
Average prescription price

Avg: $80

SRIDHAR BHASKARA MD

Interventional Pain Medicine

346

$16.1K

100
39 are 65+

36%
patients receiving schedule two controlled substances

Avg: 40%

29%
patients receiving schedule three controlled substances

Avg: 39%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 18%

$47
Average prescription price

Avg: $80

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank